Cellectis CLLS Income Statement (2013-2026)

NASDAQ CLLS
$3.25 -0.07 (-2.11%)
As of: Sep 4, 2026 · 2:07 PM EDT
Reported Financials

Cellectis Quarterly Income Statement

Periods 48 quarters
Latest Jun 2026

Cellectis reported revenue of $5.23M and net income of -$21.82M for the quarter ended Jun 2026, down 68.7% year over year. This income statement covers 48 quarters of results from Dec 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Dec2013 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
8.31M10.26M1.67M1.31M0.17M16.02M0.14M0.18M0.15M0.28M4.53M8.06M16.20M12.72M10.65M16.73M35.17M12.72M5.78M5.23M
Cost of RevenueCost of Rev
9.21M0.24M0.39M0.33M0.37M0.69M0.33M0.06M0.37M-0.34M
Gross Profit
-0.90M-0.06M0.03M0.98M-0.19M0.04M-0.20M0.12M-0.21M0.63M
Operating items
Research & DevelopmentR&D
-34.32M-29.54M-26.60M25.63M-23.84M-21.43M-21.41M22.20M-19.07M-24.96M-22.32M23.52M-23.83M-20.87M-21.93M-23.08M-24.07M-24.44M-27.19M-24.98M
Selling, General & AdministrativeSG&A
-9.68M-6.51M-6.06M4.83M-4.90M-1.70M-4.96M3.95M-3.23M-4.67M-5.10M3.88M-5.17M-4.93M-4.70M-5.08M-5.21M-4.93M-5.59M-5.74M
Other Operating ExpensesOther Opex
0.02M0.01M0.02M0.75M-0.12M0.84M-0.61M0.53M-0.01M-1.20M0.04M0.69M0.17M-0.05M0.43M0.38M0.15M-0.32M0.06M0.29M
Operating ExpensesOpex
-53.20M-36.28M-33.03M30.04M-29.23M-22.98M-26.99M25.62M-22.31M-31.57M-27.39M-26.71M-28.82M-25.84M-26.21M-27.78M-29.12M-29.56M-32.72M-30.43M
Operating IncomeOp. Inc
-42.37M-24.56M-29.23M-27.31M-27.35M-5.66M-27.83M-23.62M-20.67M-41.80M-20.89M-17.21M-10.77M12.11M-14.18M-9.59M8.04M-17.35M-25.17M-23.52M
EBIT
-42.37M-24.56M-29.23M-27.31M-27.35M-5.66M-27.83M-23.62M-20.67M-41.80M-20.89M-17.21M-10.77M12.11M-14.18M-9.59M8.04M-17.35M-25.17M-23.52M
Non-operating items
Non Operating Interest Expenses
-1.36M1.69M-1.09M-13.68M-5.18M16.28M-1.62M-17.56M-3.14M16.65M-15.41M2.44M-10.25M-19.70M-10.91M-11.41M-4.44M-3.01M
Interest & Investment IncomeInt & Inv Inc
2.27M9.99M2.90M-6.28M0.78M10.44M4.92M5.35M29.41M8.39M3.06M14.68M6.30M5.54M3.46M2.02M11.89M4.74M
Other Non Operating IncomeOther Non Op Inc.
12.92M2.71M-0.13M-0.26M-0.21M-0.07M-0.08M0.10M0.16M-0.17M-0.15M0.03M0.37M-0.56M0.75M0.29M-0.28M-0.41M
Non Operating IncomeNon Op. Inc.
0.01M0.48M
Net income details
EBT
-42.37M-7.06M-5.62M-19.01M-23.37M-2.84M-21.88M4.74M-0.65M-118.07M11.65M-25.50M2.92M-38.30M2.37M15.65M22.41M-3.93M-8.83M-15.77M
Tax ProvisionsTaxes
-0.09M0.26M-0.11M-0.01M0.26M-0.19M0.06M-0.51M-0.51M-0.05M-0.03M
Profit After TaxPAT
-40.07M-28.08M-34.76M-19.45M-31.27M-28.56M-32.52M-29.72M-17.48M-41.80M5.64M-25.27M-23.06M5.92M-18.13M-23.74M0.59M-26.32M-17.77M-21.82M
Income from Non-Controlling InterestsInc. Minority
-2.66M-3.08M-2.85M-0.51M-2.80M-1.74M-2.45M-4.93M
Income from Continuing OperationsIncome (Continuing)
-42.37M-7.06M-5.62M-19.01M-23.37M-2.75M-21.88M4.48M-0.55M-118.06M11.39M-25.31M2.86M-37.78M2.37M15.65M22.41M-3.42M-8.78M-15.75M
Income from Discontinued OperationsIncome (Discontinued)
-6.65M-6.44M-0.44M-5.72M-2.86M-4.69M13.08M
Consolidated Net IncomeConsol Net Inc.
-42.37M-13.71M-12.06M-19.45M-29.09M-5.61M-26.57M17.56M-0.55M-118.06M11.39M-25.31M2.86M-37.78M2.37M15.65M22.41M-3.42M-8.78M-15.75M
Income towards Parent CompanyParent Net Inc
-37.41M-25.00M-31.91M-18.95M-28.47M-26.82M-30.07M-11.71M-17.48M-41.80M5.64M-25.27M-23.06M5.92M-18.00M-23.74M0.59M-260.00-18.00M-15.75M
Net Income towards Common StockholdersNet Income
-37.41M-25.00M-31.91M-18.95M-28.47M-26.82M-30.07M-11.71M-17.48M-41.80M5.64M-25.27M-23.06M5.92M-18.00M-23.74M0.59M-260.00-18.00M-15.75M
Additional items
EPS (Basic)
-0.88-0.56-0.71-0.42-0.64-0.59-0.66-0.26-0.38-0.730.10-0.44-0.400.07-0.20-0.260.010.00-0.18-0.16
EPS (Diluted)
-1.04-0.56-0.71-0.42-0.64-0.59-0.66-0.26-0.38-0.730.10-0.44-0.400.07-0.20-0.260.010.00-0.18-0.16
Shares Outstanding
42.50M44.82M44.82M44.82M44.82M45.55M45.55M45.55M45.55M57.01M57.01M57.01M57.01M90.57M90.57M90.57M90.57M100.28M100.28M100.28M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
35.81M44.82M44.82M44.82M44.82M45.55M45.55M45.55M45.55M57.01M57.01M57.01M57.01M90.57M90.57M90.57M90.57M100.28M100.28M100.28M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
45.48M45.68M134.00M100.09M100.09M100.09M100.34M
EBITDA
-42.37M-24.56M-29.23M-27.31M-27.35M-5.66M-27.83M-23.62M-20.67M-41.80M-20.89M-17.21M-10.77M12.11M-14.18M-9.59M8.04M-17.35M-25.17M-23.52M
Interest ExpensesInt Expense
-1.36M1.69M-1.09M-13.68M-5.18M16.28M-1.62M-17.56M-3.14M16.65M-15.41M2.44M-10.25M-19.70M-10.91M-11.41M-4.44M-3.01M
Tax Rate
3.07%5.45%16.26%0.01%2.25%0.76%2.02%1.34%13.08%0.52%0.16%